Neoadjuvant therapy for lung cancer: a real-world study
Part of Cancer, Lungs & breathing clinical trials.
This study observes patients with lung cancer who receive neoadjuvant therapy (treatment before surgery) to understand how well it works in everyday medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of non-small cell or small cell lung cancer.
- You must have received neoadjuvant therapy (treatment before surgery) for your lung cancer.
- You must be willing to sign a consent form and agree to follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how “before-surgery” (neoadjuvant) lung cancer treatments change the tumor environment by monitoring patients during care. It may help doctors better choose therapies and predict who benefits from treatment.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
This trial looks at how well different treatments work before surgery for early-stage non-small cell lung cancer (NSCLC). It aims to help doctors understand which pre-surgery therapies lead to the best outcomes.
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
This study looks at the medical records of people with advanced non-small cell lung cancer to understand what treatments they received and whether those treatments follow official guidelines. It may help doctors learn how to improve care for future patients.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.